Monte Rosa Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Monte Rosa Stock Summary

Monte Rosa competes with Nkarta, Lyell Immunopharma, Generation Bio, Sana Biotechnology, and Design Therapeutics. Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the bodys natural mechanisms to selectively degrade therapeutically relevant proteins. Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is headquartered in Boston, Massachusetts. Monte Rosa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 93 people.

Monte Rosa Key Financial Ratios

Monte Rosa Key Balance Sheet Accounts

Monte Rosa Key Income Statement Accounts

Monte Rosa Key Cash Accounts

Monte Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Monte Rosa's current stock value. Our valuation model uses many indicators to compare Monte Rosa value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Monte Rosa competition to find correlations between indicators driving Monte Rosa's intrinsic value. More Info.Monte Rosa Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Monte Rosa's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Monte Rosa by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Monte Rosa Therapeutics Systematic Risk

Today, most investors in Monte Rosa Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Monte Rosa's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Monte Rosa growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Monte Rosa help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Monte Rosa Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Monte Rosa Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Monte Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Monte Rosa's daily price indicators and compare them against related drivers.

When running Monte Rosa's price analysis, check to measure Monte Rosa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Monte Rosa is operating at the current time. Most of Monte Rosa's value examination focuses on studying past and present price action to predict the probability of Monte Rosa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Monte Rosa's price. Additionally, you may evaluate how the addition of Monte Rosa to your portfolios can decrease your overall portfolio volatility.